High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26031153 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Natasa Tosic und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Leukemia, Lymphocytic, Chronic, B-Cell, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Science and Technological Development, Republic of Serbia.
Abstract (Originalsprache)
Long non-coding RNAs (lncRNAs) play complex roles at multiple levels of gene regulation, thus modulating key cellular processes involved in the pathogenesis and progression of cancer. Aberrant expression of lncRNAs has been reported in various malignancies, including chronic lymphocytic leukemia (CLL). We investigated the expression of lnc-IRF2-3 and lnc-KIAA1755-4 in peripheral blood mononuclear cells of 112 previously untreated CLL patients by quantitative reverse-transcriptase polymerase chain reaction. Both lncRNAs were found to be overexpressed in CLL samples in comparison to healthy controls, and their high levels were associated with adverse clinico-biological characteristics of patients at diagnosis. High lnc-IRF2-3 expression was associated with high leukocyte and lymphocyte counts, high β2-microglobulin, advanced Binet stage, unfavorable cytogenetics, CD38-positivity and IGHV-unmutated status. Regarding lnc-KIAA1755-4, its high expression was associated with high leukocyte count, lymphocyte count, β2-microglobulin, lactate dehydrogenase and low hemoglobin, as well as with IGHV-unmutated status. In addition, we observed shorter time to first treatment and overall survival of patients expressing high levels of both lncRNAs in comparison to low-expressing patients. In summary, our study showed that high lnc-IRF2-3 and lnc-KIAA1755-4 expression at diagnosis predicts poor survival in CLL. The mechanisms of their upregulation, as well as their specific targets in CLL cells, remain to be elucidated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia.
- Clinic for Hematology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
- School of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
ORCID-Profile: Natasa Tosic, Kristina Tomic Vujovic, Nikola Kotur, Biljana Stankovic, Irena Marjanovic, Darko Antic, Jelena Ivanovic
Förderung
- Ministry of Education, Science and Technological Development, Republic of Serbia
Zitieren
APA
Tosic, N., Tomic Vujovic, K., Vukovic, V., Kotur, N., Stankovic, B., Marjanovic, I., Antic, D., Sarac, S., Bibic, T., Ivanovic, J., Zukic, B., & Karan-Djurasevic, T. (2025). High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031153
Vancouver
Tosic N, Tomic Vujovic K, Vukovic V, Kotur N, Stankovic B, Marjanovic I, et al. High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031153
BibTeX
@article{Tosic2025,
author = {Tosic, Natasa and Tomic Vujovic, Kristina and Vukovic, Vojin and Kotur, Nikola and Stankovic, Biljana and Marjanovic, Irena and Antic, Darko and Sarac, Sofija and Bibic, Tamara and Ivanovic, Jelena and Zukic, Branka and Karan-Djurasevic, Teodora},
title = {High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26031153}
}
EUVIMED